يعرض 1 - 10 نتائج من 93 نتيجة بحث عن '"SOMATOSTATIN"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    تقرير

    المصدر: Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/ Paragangliomas Previously Treated With Systemic Radiolig and Therapy

  2. 2
    تقرير

    المساهمون: Michael D. Jensen, Principal Investigator

    المصدر: Stimulation of Regional Lipolysis and Adipocyte Lipolysis Proteins

  3. 3
    تقرير

    المؤلفون: Canadian Cancer Trials Group

    المصدر: A Randomised Study of Cessation of Somatostatin Analogues After Peptide Receptor Radionuclide Therapy in Mid-Gut Neuroendocrine Tumours (STOPNET)

  4. 4
    تقرير

    المؤلفون: Bispebjerg Hospital

    المساهمون: Nicolai Jacob Wewer Albrechtsen, Associate Professor, MD, PhD

    المصدر: Direct Versus Indirect Effect of Amino Acids on Hepatokines in Healthy Subjects and Patients With Non-alcoholic Fatty Liver Disease

  5. 5
    تقرير

    المصدر: Dosimetry-Guided 177Lu-DOTATATE Treatment Planning Using 64Cu-DOTATATE as a Surrogate

  6. 6
    تقرير

    المصدر: LUTATHERA Injection General Use Result Survey (Somatostatin Receptor-positive Neuroendocrine Tumor, CAAA601A11401)

  7. 7
    تقرير

    المصدر: Evaluation of Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients (ACRO-BONE)

  8. 8
    تقرير
  9. 9
    تقرير

    المصدر: The Effects of Endoscopy Combined With Partial Splenic Artery Embolization in the Treatment of Cirrhosis With Esophageal and Gastric Varices Complicated With Hyperplenism or Splenomegaly:A Randomized Controlled Study.

  10. 10
    تقرير

    المصدر: A Post Marketing Surveillance on Lutathera® (Lutetium (177Lu) Oxodotreotide, 177Lu-DOTA0-Tyr3-Octreotate) in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) in Korea